This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: non-vitamin K antagonist oral anticoagulants (NOACs)

Use of NOAC drugs in DC cardioversion for patients with non-valvular AF

August 2018 Br J Cardiol 2018;25(suppl 1):S18–S20 doi:10.5837/bjc.2018.s05

Use of NOAC drugs in DC cardioversion for patients with non-valvular AF

Craig S Barr

Abstract

Introduction Direct current cardioversion (DCCV) is a frequently used and effective strategy for the restoration of sinus rhythm in patients with atrial fibrillation (AF) that is persistent and of recent onset. It has been undertaken for almost 60 years.1 While thromboembolic events are associated with this procedure, prior anticoagulation reduces this risk to less than 1%.2 Anticoagulation is given to patients for at least three weeks prior to the procedure and maintained long term, unless they are at low future risk of stroke and systemic embolism (which is very few patients presenting for cardioversion), namely men with a CHA2DS2-VASc sco

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now